iPierian

Careers Contact

  • Company
    • About Us
    • Leadership
      • Management Team
      • Board of Directors
      • Scientific Advisory Board
      • Key Advisors
    • Investors
    • Careers
      • Open Positions
    • Contact
  • Technology
    • Technology Overview
    • iPS Cell Technology
    • Differentiation
      • Proof of Concept
      • Advancing Cellular Programming
      • Scientific Advantages
    • Phenotypic Assay Development
  • Therapeutic Areas
    • Therapeutic Areas Overview
    • Neurological Diseases
    • Cardiovascular Disease
    • Metabolic Diseases
  • Collaborators
    • Collaborators Overview
  • News & Events
    • Newsroom
    • Press Releases
      • 2010
      • 2009
      • 2008
    • Media Kit
  • Newsroom
  • Press Releases
    • 2010
    • 2009
    • 2008
  • Media Kit

Press Releases

Print
Email

2010

02/22/10
iPierian Appoints Dr. Michael Venuti as President and Chief Scientific Officer

 

01/28/10
First iPierian Patent for Induced Pluripotent Stem Cell Technology Granted by United Kingdom Intellectual Property Office

 

2009

10/21/09
iPierian To Collaborate with Johns Hopkins University on $3.7 Million NIH Grand Opportunities Grant

 

09/01/09
iPierian Appoints Dr. Matthew J. Plunkett as Chief Financial Officer

 

08/06/09
iPierian Appoints Dr. Chad Cowan and Dr. Konrad Hochedlinger to Scientific Advisory Board

 

07/08/09
iZumi Bio and Pierian Merge to form iPierian to Advance Cellular Reprogramming

 

06/11/09
iZumi Bio Appoints Dr. Corey Goodman to Board of Directors and Scientific Advisory Board

 

05/06/09
iZumi Bio Appoints Dr. Berta Strulovici as Chief Technology Officer and Dr. Dushyant Pathak as Vice President of Business Development

 

04/14/09
iZumi Bio and Kyoto University Form Collaboration to Advance Induced Pluripotent Stem Cell Technology

 

02/12/09
iZumi Bio. Inc., Appoints John Walker as Chief Executive Officer

 

2008

08/06/08
iZumi Bio, Inc. Recruits Leading iPS Scientist, John Dimos, to Translate Stem Cell Breakthrough into Patient Benefits

 

06/16/08
The Gladstone Institutes and Izumi Bio Announce Broad Partnership in Regenerative Medicine And Cardiovascular Disease

 

© 2009 iPierian Inc. All rights reserved.

Home Site Map